Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning
A structured, comprehensive way to understand global investing
Read about our journey and get to know the leadership team at Vested
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is a modified equal-dollar weighted index to objectively identify and select stocks from the Russell 1000® Index in the health care sector that may generate positive alpha relative to traditional passive-style indices through the use of the AlphaDEX® selection methodology. more
| Time Frame | FXH | S&P500 |
|---|---|---|
| 1-Week Return | -1.34% | -0.87% |
| 1-Month Return | -2.94% | 0.08% |
| 3-Month Return | 4.53% | 2.25% |
| 6-Month Return | 16.7% | 16.36% |
| 1-Year Return | 15.63% | 14.04% |
| 3-Year Return | 33.66% | 78.49% |
| 5-Year Return | 9.18% | 75.6% |
| 10-Year Return | 113.67% | 253.86% |
| Time Frame | FXH | S&P500 |
|---|---|---|
| 1-Week Return | -50.51% | -36.60% |
| 1-Month Return | -30.45% | 0.98% |
| 3-Month Return | 19.68% | 9.44% |
| 6-Month Return | 36.77% | 35.97% |
| 1-Year Return | 15.63% | 14.04% |
| 3-Year Return | 10.15% | 21.30% |
| 5-Year Return | 1.77% | 11.92% |
| 10-Year Return | 7.89% | 13.47% |
| Stock name | Ticker | Weight |
|---|---|---|
Natera, Inc. | NTRA | 3.3% |
Regeneron Pharmaceuticals, Inc. | REGN | 2.8% |
Universal Health Services, Inc. (Class B) | UHS | 2.61% |
Pfizer Inc. | PFE | 2.59% |
Guardant Health, Inc. | GH | 2.58% |
Solventum Corporation | SOLV | 2.52% |
Halozyme Therapeutics, Inc. | HALO | 2.41% |
Boston Scientific Corporation | BSX | 2.3% |
Zimmer Biomet Holdings, Inc. | ZBH | 2.28% |
Corcept Therapeutics Inc. | CORT | 2.23% |
Tenet Healthcare Corporation | THC | 2.18% |
Centene Corporation | CNC | 2.11% |
The Cigna Group | CI | 2.11% |
Globus Medical, Inc. (Class A) | GMED | 2.06% |
Encompass Health Corporation | EHC | 1.98% |
Medline Inc. (Class A) | MDLN | 1.93% |
QIAGEN N.V. | QGEN | 1.87% |
ResMed Inc. | RMD | 1.87% |
Medtronic Plc | MDT | 1.86% |
Incyte Corporation | INCY | 1.8% |
Axsome Therapeutics, Inc. | AXSM | 1.76% |
DaVita Inc. | DVA | 1.72% |
Elevance Health Inc. | ELV | 1.69% |
Doximity, Inc. (Class A) | DOCS | 1.65% |
Eli Lilly and Company | LLY | 1.62% |
Zoetis Inc. | ZTS | 1.6% |
Gilead Sciences, Inc. | GILD | 1.56% |
Becton, Dickinson and Company | BDX | 1.56% |
Medpace Holdings, Inc. | MEDP | 1.54% |
Quest Diagnostics Incorporated | DGX | 1.47% |
Labcorp Holdings Inc. | LH | 1.45% |
Viatris Inc. | VTRS | 1.45% |
United Therapeutics Corporation | UTHR | 1.43% |
Ascendis Pharma A/S | ASND | 1.42% |
Bristol-Myers Squibb Company | BMY | 1.41% |
Revolution Medicines, Inc. | RVMD | 1.41% |
Exelixis, Inc. | EXEL | 1.4% |
Biogen Inc. | BIIB | 1.38% |
GE HealthCare Technologies Inc. | GEHC | 1.37% |
Neurocrine Biosciences, Inc. | NBIX | 1.35% |
Arrowhead Pharmaceuticals, Inc. | ARWR | 1.33% |
Steris Plc | STE | 1.31% |
Veeva Systems Inc. (Class A) | VEEV | 1.27% |
IQVIA Holdings Inc. | IQV | 1.17% |
Tempus AI, Inc. (Class A) | TEM | 1.16% |
Thermo Fisher Scientific Inc. | TMO | 1.11% |
Agilent Technologies, Inc. | A | 1.07% |
Abbott Laboratories | ABT | 0.91% |
HCA Healthcare, Inc. | HCA | 0.89% |
Chemed Corporation | CHE | 0.87% |
AbbVie Inc. | ABBV | 0.86% |
Vertex Pharmaceuticals Incorporated | VRTX | 0.86% |
Henry Schein, Inc. | HSIC | 0.84% |
Organon & Co. | OGN | 0.83% |
Madrigal Pharmaceuticals, Inc. | MDGL | 0.78% |
BridgeBio Pharma, Inc. | BBIO | 0.73% |
Ionis Pharmaceuticals, Inc. | IONS | 0.73% |
Align Technology, Inc. | ALGN | 0.71% |
Illumina, Inc. | ILMN | 0.64% |
Revvity, Inc. | RVTY | 0.56% |
Bio-Rad Laboratories, Inc. (Class A) | BIO | 0.54% |
DexCom, Inc. | DXCM | 0.53% |
Danaher Corporation | DHR | 0.48% |
Merck & Co., Inc. | MRK | 0.47% |
Amgen Inc. | AMGN | 0.46% |
The Ensign Group, Inc. | ENSG | 0.44% |
BioMarin Pharmaceutical Inc. | BMRN | 0.44% |
Johnson & Johnson | JNJ | 0.44% |
West Pharmaceutical Services, Inc. | WST | 0.43% |
IDEXX Laboratories, Inc. | IDXX | 0.4% |
Envista Holdings Corporation | NVST | 0.37% |
Stryker Corporation | SYK | 0.35% |
The Cooper Companies, Inc. | COO | 0.32% |
US Dollar | US.Dollar | 0.07% |
| Sector | Weight |
|---|---|
|
Health care | 100.00% |
First Trust Health Care AlphaDEX® Fund (FXH) share price today is $129.1.
Yes, Indians can buy shares of First Trust Health Care AlphaDEX® Fund (FXH) on Vested. To buy FXH from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of First Trust Health Care AlphaDEX® Fund (FXH) on Vested. You can start investing in First Trust Health Care AlphaDEX® Fund (FXH) with a minimum investment of $1.
The 52-week high price of First Trust Health Care AlphaDEX® Fund (FXH) is $135.52. The 52-week low price of First Trust Health Care AlphaDEX® Fund (FXH) is $104.12.
The stock symbol (or ticker) of First Trust Health Care AlphaDEX® Fund is FXH.
Yes, you can setup SIP in First Trust Health Care AlphaDEX® Fund shares. Follow the below steps to create the SIP:
Here is the historical performance of FXH on the Vested app.
The expense ratio of First Trust Health Care AlphaDEX® Fund (FXH) is 0.62%.
Link copied